FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to biotechnology. Described are an antibody and its functional fragment, containing antigen-binding regions, specific to MST1R. The invention also relates to nucleic acid sequences, coding the said antibodies, vectors, containing then, pharmaceutical compositions and sets with instructions for application. The invention can be used for the treatment of MST1R-associated disorders and conditions.
EFFECT: antibodies by the invention can be used in the field of diagnostics, as well as for further investigation of the MST1R role in progressing of tumour-associated disorders.
52 cl, 37 dwg, 2 tbl, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ANTIBODY OR FRAGMENT THEREOF WITH HIV-NEUTRALISING ACTIVITY | 2005 |
|
RU2380378C2 |
| MOLECULES WHICH BIND TO 4-1BB | 2011 |
|
RU2710717C2 |
| INTERFERON ALPHA 1 RECEPTOR ANTIBODIES AND USE THEREOF | 2005 |
|
RU2600884C2 |
| ANTI-SIRPα ANTIBODY AND USE THEREOF | 2021 |
|
RU2822496C1 |
| METHOD OF DESTROYING CELLS USING EFFECTOR FUNCTIONS OF ANTI-EphA4 ANTIBODIES | 2007 |
|
RU2429246C2 |
| ANTIBODY OR FRAGMENT THEREOF, HAVING NEUTRALISING EFFECT ON HIV, BUT NOT ON IL2 | 2005 |
|
RU2393873C2 |
| MONOCLONAL ANTIBODIES AGAINST HUMAN TIM-3 | 2019 |
|
RU2777336C1 |
| ANTI-GM-CSF ANTIBODIES AND USING THEM | 2006 |
|
RU2447085C2 |
| ANTIBODIES AGAINST THE PROGRAMMED DEATH LIGAND (PD-L1) AND APPLICATION THEREOF | 2019 |
|
RU2761638C1 |
| HUMAN ANTI-CD38-ANTIBODIES AND THEIR APPLICATION | 2005 |
|
RU2402568C2 |
